Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Drug Pricing Challenges Poised To Impact Pharma Growth, Leerink Warns

Oct 10 2018

• By Jessica Merrill

Businesswoman Hands On Crystal Ball On Black Background. Fortune Teller Predicting Future

Related Content

Novartis Puts A Halt To Drug Price Increases While Awaiting More On Trump's Blueprint

Jul 18 2018

We Haven’t Ruled Out Drug Price Increases, Says Regeneron’s Schleifer

Oct 09 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Who's Promised What: A Guide To Pharma Drug Pricing Pledges

Jul 23 2018

Related Companies

Pfizer Inc.

Novartis AG

AbbVie Inc.

Amgen, Inc.

Alexion Pharmaceuticals Inc.

Regeneron Pharmaceuticals, Inc.

Merck & Co., Inc.

Bristol Myers Squibb Company

Eli Lilly and Company

Johnson & Johnson

Biogen, Inc.

Gilead Sciences, Inc.

Roche Holding AG

Sanofi

GSK plc

Additional Topics

Pricing Debate Business Strategies Commercial BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window